Skeletal Dysplasia Account Manager - Oklahoma City/Tulsa

BridgeBio
Oklahoma City, Dallas, Houston, San Antonio, New Orleans, Nashville, Phoenix
Workplace: RemoteFull timeUSD 155,000 - 210,000 annuallyFunction: Customer Success & Account ManagementExperience: 4-10 yearsEducation: bachelorsSkills: ["Communication","Leadership","Organizational skills","Analytical skills","Integrity"]

Drive the launch of Infigratinib across multiple Southwest territories, developing territory plans and using sales and target data to exceed goals. Build deep expertise in Infigratinib and achondroplasia to engage HCPs in clinically relevant, compliant discussions. Partner with Field Medical, reimbursement, and the HUB to maximize customer and family satisfaction, and collaborate cross-functionally to expand advocacy with KOLs for BridgeBio.

Loading

Loading job details...

Preparing the role view and application actions.

FursaFursa
BridgeBio
BridgeBio
1 month ago

Skeletal Dysplasia Account Manager - Oklahoma City/Tulsa

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI
Last checked: 11 hours agoStatus: Live

Job Summary

Drive the launch of Infigratinib across multiple Southwest territories, developing territory plans and using sales and target data to exceed goals. Build deep expertise in Infigratinib and achondroplasia to engage HCPs in clinically relevant, compliant discussions. Partner with Field Medical, reimbursement, and the HUB to maximize customer and family satisfaction, and collaborate cross-functionally to expand advocacy with KOLs for BridgeBio.
Location: Oklahoma City, Dallas, Houston, San Antonio, New Orleans, Nashville, Phoenix
Workplace: Remote
Employment Type: Full time
Job Function: Customer Success & Account Management
Seniority: Mid level

Key Responsibilities

  • •Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and skeletal dysplasia clinics to meet and exceed sales goals.
  • •Demonstrate deep expertise in Infigratinib and achondroplasia and engage HCPs in clinically relevant, compliant discussions.
  • •Use sales and target data to identify growth opportunities, anticipate territory challenges, and adjust priorities as needed.
  • •Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction.
  • •Build and maintain relationships with KOLs with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio, operating with a One Bridge mindset.
Travel: Extensive travel

Pay and Benefits

Salary: USD 155,000 - 210,000 annually
Perks:Health InsuranceDentalVision401kEquityHsaFsaPaid LeaveParental LeaveAnnual BonusMeal Allowance

Key Requirements

  • •8–10 years in pharmaceutical or biotech and 4+ years in rare disease, genetic disease, or skeletal dysplasia (achondroplasia or pediatric rare disease experience preferred).
  • •BS/BA required; MBA a plus.
  • •Willingness to travel extensively.
  • •Proven product/indication launch experience, creating demand through disease-state and stakeholder education.
  • •Experience in account management and strategy, analyzing complex accounts and driving measurable impact.
Experience:4-10 yearsPharmaceuticalBiotechRare diseaseGenetic disease
Education:Bachelor's
Skills:CommunicationLeadershipOrganizational skillsAnalytical skillsIntegrity
Languages:English
Tech Stack:AIAI-powered toolsLinkedIn LearningBetterUpLifeLabs

Company Brief

BridgeBio
Develops medicines for patients with genetic diseases by advancing targeted therapeutics from discovery through clinical development and commercialization, focusing on genetically defined diseases with high unmet medical need.
Industry: Biotech
Company Size: Large (251 to 1,000 employees)
Growth: Public Company
Valuation: Public Company (Market Cap in USD)
Funding: IPO / Publicly Listed
Headquarters: Palo Alto, United States
Founded: 2015
WebsiteLinkedIn